Circumstantial evidence based on the forced overexpression of VE-cadherin in MCF-7 and MDA-MB-231 breast cancer cells supports the view that VE-cadherin promotes tumor-endothelial interactions also in human cells [16]. Here, CDH5 is linked to breast cancer.